HighTower Advisors’s Ventyx Biosciences VTYX Stock Holding History

HighTower Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,000	Closed	-$5.7K	–	4004
2025 Q1	$5.7K	Buy	19,000 +7,000	+58%	+$12K	﹤0.01%	3578
2024 Q4	$7.2K	Buy	+12,000	New	+$27.2K	﹤0.01%	3603
2024 Q3	–	Sell	-2,000	Closed	-$1.4K	–	3998
2024 Q2	$1.4K	Buy	+2,000	New	+$8.31K	﹤0.01%	3551

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HighTower Advisors's VTYX Position: Q1 2026 in Review

HighTower Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 85,972 shares — an estimated $776K sold.

HighTower Advisors first reported a position in VTYX in Q2 2022 and held it in 15 quarters. The position peaked at $5.33M in Q3 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

HighTower Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
HighTower Advisors sold 85,972 Ventyx Biosciences shares in Q1 2026, an estimated $776K.
HighTower Advisors first reported a position in Ventyx Biosciences in Q2 2022 and held it in 15 quarters.
HighTower Advisors's Ventyx Biosciences position peaked at $5.33M in Q3 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.